ArticleJournal of experimental & clinical cancer research : CR2024
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer.
Yaxun Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it